Jiangsu Sihuan Bioengineering Co., Ltd (SHE:000518)

China flag China · Delayed Price · Currency is CNY
2.990
0.00 (0.00%)
Apr 22, 2026, 10:05 AM CST
Market Cap3.08B +28.3%
Revenue (ttm)344.38M +69.2%
Net Income-37.09M
EPS-0.04
Shares Out1.03B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,211,300
Average Volume13,761,291
Open2.950
Previous Close2.990
Day's Range2.950 - 3.010
52-Week Range1.720 - 3.180
Beta0.26
RSI53.88
Earnings DateApr 18, 2026

About SHE:000518

Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers delusheng and xindelusheng, an anti-tumor biotherapeutic drug for the treatment of kidney cancer, malignant melanoma, and cancerous chest and abdominal mass. It also engages in breeding and sales of flowers and seedlings; and landscaping projects. Jiangsu Sihuan Bioengineering Co., Ltd. was founded in 1992 and is headquartered in Jiangyin, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1992
Employees 277
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000518
Full Company Profile

Financial Performance

In 2025, SHE:000518's revenue was 344.38 million, an increase of 69.22% compared to the previous year's 203.52 million. Losses were -37.09 million, -66.28% less than in 2024.

Financial Statements